Astrazeneca (AZN) Capital Expenditures (QoQ) (2009 - 2026)

Astrazeneca (AZN) Capital Expenditures (QoQ) (2009 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Astrazeneca 67.83 Bn 59.89 Bn 12.61 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 -111.93%
Dec 31, 2025 768.22%
Sep 30, 2025 -4.10%
Jun 30, 2025 -53.61%
Mar 31, 2025 -113.66%
Dec 31, 2024 853.00%
Sep 30, 2024 -9.16%
Jun 30, 2024 8.39%
Jun 30, 2023 -9.31%
Jun 30, 2022 -15.53%
Mar 31, 2022 -123.00%
Dec 31, 2021 466.15%
Mar 31, 2021 -124.24%
Jun 30, 2020 4.35%
Mar 31, 2020 42.77%
Dec 31, 2019 70.83%
Mar 31, 2016 42.82%
Dec 31, 2015 -17.86%
Sep 30, 2015 -31.54%
Jun 30, 2015 -19.54%